Advertisement
The earnings release will be available on the investor relations page ofits website at: http://www.3sbio.com/en/News/ShowInfo_nnn5.aspx?ID=64 .
Advertisement
Following the earnings announcement, 3SBio Inc. senior management willhost a conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm(Beijing/Hong Kong) on Thursday, May 15, 2008 to discuss its 2008 firstquarter financial results and recent business activity. The conference callmay be accessed by calling (US) +1 480 248 5081 / (UK) +44 (0) 20 8515 2301 /(HK) +852 3009 5027. A telephone replay will be available shortly after thecall until May 29, 2008 at (US) +1 303 590 3030/ (UK) +44 (0)20 7154 2833,Passcode: 3872203; and (HK) +852 2287 4304, Passcode: 030 110#.
A live webcast of the conference call and replay will be available on theinvestor relations page of 3SBio's website at:http://www.3sbio.com/en/News/ShowInfo_nnn5.aspx?ID=64 .
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused onresearching, developing, manufacturing and marketing biopharmaceuticalproducts, primarily in China.
For more information, please visit 3SBio on the web at:http://www.3sbio.com .For more information, please contact: Investor Contact: Kevin Teo, CFO 3SBio Inc. Tel: +86-24-2581-1820 Investor Relations (US): Mahmoud Siddig Taylor Rafferty Tel: +1-212-889-4350 Investor Relations (HK): Ruby Yim Taylor Rafferty Tel: +852-3196-3712 Media Contact: Jason Marshall Taylor Rafferty Tel: +1-212-889-4350
SOURCE 3SBio Inc.
